Advertisement

Topics

Teva Parenteral Medicines Company Profile

21:03 EST 14th December 2018 | BioPortfolio


News Articles [866 Associated News Articles listed on BioPortfolio]

Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines

An Eli Lilly drug developed to prevent migraine headache pain before it starts has won FDA approval. The FDA decision announced late Thursday marks the third drug in this new class of medicines to rec...

Teva Pharmaceutical Posting Strong Gain On FDA Approval Of Ajovy

PETAH TIKVA (dpa-AFX) - After gapping open higher, shares of Teva Pharmaceutical (TEVA) continue to see significant strength in afternoon trading on Monday. Teva is currently up by 3.9 percent.The...

Teva To Discontinue Clinical Trial Of Fremanezumab For Chronic Cluster Headache

Israeli generic medicines producer Teva Pharmaceutical Industries (TEVA) announced Friday that it will discontinue the trial of fremanezumab for use in chronic cluster headache, which is part of the l...

Parenteral Antibiotics Prior to Emergency Department Discharge for Children with UTI?

A single parenteral dose of antibiotics did not prevent ED revisits or eventual hospital admission.

89Bio Joins NASH Chase with a Teva Drug and $65M in Funding

The competition to develop a treatment for nonalcoholic steatohepatitis, a serious liver disorder, has another player. 89Bio launched Thursday with $65 million in financing and a lead compound origina...

Teva Pharmaceuticals Aktie: Buffett glaubt an das Unternehmen!

Durch Missmanagement geriet der Pharmariese Teva Pharmaceuticals in die Krise. Der Aktienkurs fiel von mehr als 30 USD auf zwischenzeitlich 11 USD zurück. Doch dann setzte die Erholung bei der Teva.....

Teva Wins FDA Nod for Migraine Drug, Sets Price in Line with Amgen’s

A Teva Pharmaceutical migraine-prevention drug has won FDA approval, the second therapy in this new drug class to receive the regulatory nod this year. The Friday approval for the Teva (NYSE: TEVA) dr...

ASPEN, Baxter launch educational video series on appropriate use of parenteral nutrition

Today the American Society for Parenteral and Enteral Nutrition, an organization which drives the science and practice of clinical nutrition, and Baxter International Inc., a global leader in clinical...

Drugs and Medications [285 Associated Drugs and Medications listed on BioPortfolio]

Silver nitrate [Teva Pharmaceuticals USA Inc]

SILVER NITRATE Solution

Terbinafine hydrochloride [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use terbinafine hydrochloride safely and effectively. See full prescribing information for terbinafine hydrochloride tablets.Terbinafine H...

Nicotine polacrilex [IVAX Pharmaceuticals Inc]

Nicotine polacrilex [IVAX Pharmaceuticals Inc]

Gemcitabine hydrochloride [Teva Parenteral Medicines, Inc.]

These highlights do not include all the information needed to use Gemcitabine for Injection, USP safely and effectively. See full prescribing information for Gemcitabine for Injection, USP. Gemcitabin...

PubMed Articles [407 Associated PubMed Articles listed on BioPortfolio]

Does consumer medicines interest reflect medicines use? An Australian observational study comparing medicines call center queries with medicines use.

Consumers have questions about their medication but the nature of these concerns and how they reflect medication use is unknown.

Prevalence and Prognostic Value of Abnormal Liver Test Results in Critically Ill Children and the Impact of Delaying Parenteral Nutrition.

In the Early versus Late Parenteral Nutrition in the Pediatric ICU randomized controlled trial, delaying parenteral nutrition to beyond day 7 (late parenteral nutrition) was clinically superior to sup...

Adolescents' knowledge and perception of risk toward medicines.

Adolescents often start to use medicines independently without having sufficient knowledge or previous experience, which can lead to the inappropriate use of the medicines.

Gut Microbiota as a Modulator of Paneth Cells During Parenteral Nutrition in Mice.

Parenteral nutrition (PN) leads to decreased production of Paneth cell-derived antimicrobial peptides and is accompanied by dysbiosis of the gut. The role of gut microbiota in regulating Paneth cell f...

A systematic review about prophylactic L-carnitine administration in parenteral nutrition of extremely preterm infants.

Preterm infants with total parenteral nutrition are at particular risk of developing carnitine deficiency with impaired tolerance of parenteral lipids. The  objective was to review the scientific l...

Clinical Trials [797 Associated Clinical Trials listed on BioPortfolio]

Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates

The goal of the study is to determine if parenteral nutrition-associated cholestasis (PNAC) is related to the amount of parenteral (intravenous) fat administered to premature babies until ...

Early Versus Late Parenteral Nutrition in the Pediatric Intensive Care Unit

In the PEPaNIC trial it is investigated whether withholding parenteral nutrition during the first week in critically ill children is beneficial, compared to the current standard of the ear...

A Trial of Taurine Supplementation in Parenteral Nutrition 1

The purpose of this study is to investigate whether the inclusion of 1g of intravenous taurine as part of the nitrogen source of parenteral nutrition reduces parenteral nutrition associate...

Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents

This multicenter observational cohort study proposes to establish the risks of short and long-term outcomes in users of parenteral micafungin and in users of other parenteral antifungal ag...

Evaluation of Omegaven™ Parenteral Nutrition in Patients With TPN-Induced Cholestasis

The purpose of this study is to determine if established parenteral nutrition (PN) associated liver disease can be reversed or its progression halted by using a parenteral fat emulsion pre...

Companies [661 Associated Companies listed on BioPortfolio]

Teva Parenteral Medicines

Teva North America Specialty Medicines

Teva Pharmaceutical Industries Ltd is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. I...

Teva Neuroscience Inc.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and...

Teva USA

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and ...

Teva Women’s Health, Inc.

Teva Women’s Health, Inc. is a U.S.-based subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), headquartered in Israel. The company produces a wide range of women...

More Information about "Teva Parenteral Medicines" on BioPortfolio

We have published hundreds of Teva Parenteral Medicines news stories on BioPortfolio along with dozens of Teva Parenteral Medicines Clinical Trials and PubMed Articles about Teva Parenteral Medicines for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Teva Parenteral Medicines Companies in our database. You can also find out about relevant Teva Parenteral Medicines Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record